Citizens JMP Reiterates Market Outperform Rating on Rhythm Pharmaceuticals (RYTM)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 rises; Apple and Palantir set to report results
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| (NASDAQ: RYTM) | Delayed: 94.47 +1.90 (2.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.57 | 52 Week High | $ | |||
| Open | $93.13 | 52 Week Low | $ | |||
| Day High | $95.35 | P/E | N/A | |||
| Day Low | $92.40 | EPS | $ | |||
| Volume | 1,014,149 | |||||
